This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Takehiro Shinozaki: Innovator in Pharmaceutical Chemistry
Introduction
Takehiro Shinozaki is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target lipid metabolism abnormalities and diabetes.
Latest Patents
Shinozaki holds a patent for a cyclic amino benzoic acid derivative. This invention relates to cyclic amino benzoic acid derivatives that are effective as human peroxisome proliferators-activated receptor (PPAR) agonists. Specifically, it targets the human PPARα isoform and includes addition salts and pharmaceutical compositions containing these compounds. The cyclic amino benzoic acid derivative is represented by a complex general formula that includes various substituents and functional groups.
Career Highlights
Shinozaki is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing therapeutic agents that can effectively manage metabolic disorders.
Collaborations
He has collaborated with notable colleagues such as Masahiro Nomura and Yasuo Takano, contributing to advancements in their shared field of expertise.
Conclusion
Takehiro Shinozaki's work exemplifies the impact of innovative research in pharmaceutical chemistry. His contributions are paving the way for new treatments in metabolic disorders, showcasing the importance of continued innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile